Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Takeda Highlights Value Of Late-Stage Pipeline
Peak Potential Of $10bn-20bn
Dec 19 2024
•
By
Ian Haydock
Takeda lays out prospects for late-stage pipeline • Source: Takeda
More from R&D
More from Neurological